Fe3+-Binding Transferrin Nanovesicles Encapsulating Sorafenib Induce Ferroptosis in Hepatocellular Carcinoma

In vivo and in vitro experiments revealed that SOR@TF-Fe3+ nanovesicles predominantly accumulate in the liver, and specifically targeted HCC cells overexpressing transferrin receptor.